UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000020255
Receipt No. R000023386
Scientific Title The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.
Date of disclosure of the study information 2016/02/01
Last modified on 2016/12/26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.
Acronym The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.
Scientific Title The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.
Scientific Title:Acronym The molecular biologic chracteristic analysis of primary fallopian tube carcinoma.
Region
Japan

Condition
Condition primary fallopian tube carcinoma
Classification by specialty
Obsterics and gynecology
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 Molecular biologic characteristic analysis of primary fallopian tube carcinoma.
Basic objectives2 Others
Basic objectives -Others It is aimed for the application to a diagnosis in examination, the preoperation of the outbreak factor of uterine tube cancer by analyzing the molecular biologic characteristic of primary fallopian tube carcinoma.
Trial characteristics_1 Others
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Clarify the molecular biologic characteristic of primary fallopian tube carcinoma.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <
Age-upper limit
90 years-old >=
Gender Female
Key inclusion criteria primary fallopian tube carcinoma
primary peritoneal carcinoma
high grade serous ovarian carcinoma
Key exclusion criteria There is particularly no it.
Target sample size 60

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Hideki Tokunaga
Organization TOHOKU UNIVERSITY
Division name Department of Gynecology and Obsterics
Zip code
Address 1-1, Seiryo-machi, Aoba-ku, Sendai
TEL 022-717-7251
Email tokunagahideki@med.tohoku.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Shoko Sakurada
Organization TOHOKU UNIVERSITY
Division name Department of Gynecology and Obstetrics
Zip code
Address 1-1, Seiryo-machi, Aoba-ku, Sendai
TEL 022-717-7251
Homepage URL
Email s.sakurada@med.tohoku.ac.jp

Sponsor
Institute Department of Gynecology and Obstetrics , Tohoku University
Institute
Department

Funding Source
Organization Department of Gynecology and Obstetrics , Tohoku University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 02 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2016 Year 02 Month 01 Day
Date of IRB
Anticipated trial start date
2016 Year 02 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We detect copy number variations and BRCA/p53 about a primary fallopian tube carcinoma, a peritoneum cancer, a high atypical degree ovary serosity adenocarcinoma.

Management information
Registered date
2015 Year 12 Month 17 Day
Last modified on
2016 Year 12 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023386

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.